产品详情
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.56 mL | 107.81 mL | 215.62 mL |
0.5 mM | 4.31 mL | 21.56 mL | 43.12 mL |
1 mM | 2.16 mL | 10.78 mL | 21.56 mL |
5 mM | 0.43 mL | 2.16 mL | 4.31 mL |
*The above data is based on the productmolecular weight 463.78. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A13030 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 463.78 |
Formula | C18H18Cl3FN4OS |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1047645-82-8 |
Synonyms | GSK2110183, GSK 2110183 |
SMILES | CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl.Cl |
产品标签
Product Questions
Product Questions
AKT inhibitor VIII (AKTI-1/2)
AKT inhibitor VIII (AKTI-1/2)是一种细胞可渗透且可逆的喹喔啉化合物,在体外激酶测定中,该化合物有效和选择…
Akt1 and Akt2-IN-1
Akt1 and Akt2-IN-1是Akt1(IC50 = 3.5 nM)和Akt2(IC50 = 42 nM)的变构抑制剂,具有有效且平衡的活性。
Perifosine (NSC-639966)
Perifosine (也为KRX-0401) 充当Akt抑制剂和PI3K抑制剂。
TIC10 isomer
TIC10通过Foxo3a使Akt和ERK失活,从而诱导TRAIL,具有优越的药物特性:跨血脑屏障传递,优异的稳定性和改善…